Medical Aspects of Chemical Warfare (2008) - The Black Vault

More documents

Recommendations

Info

Long-Term Health Effects of Chemical Threat Agents57. Anslow WP, Houch CR. Systemic pharmacology and pathology of sulfur and nitrogen mustards. In: Chemical WarfareAgents and Related Chemical Problems. Washington, DC: Office of Scientific Research and Development; 1946.58. Lohs K. Delayed Toxic Effects of Chemical Warfare Agents. Stockholm, Sweden: Almqvist & Wilksell; 1979. SIPRI monograph.59. Lawley PD, Lethbridge JH, Edwards PA, Shooter KV. Inactivation of bacteriophage T7 by mono- and difunctionalsulphur mustards in relation to crosslinking and depurination of bacteriophage DNA. J Mol Biol. 1969;39:181–198.60. Flamm WG, Bernheim NJ, Fishbein L. On the existence of intrastrand crosslinks in DNA alkylated with sulfur mustard.Biochim Biophys Acta. 1970;224:657–659.61. Fox M, Scott D. The genetic toxicology of nitrogen and sulphur mustard. Mutat Res. 1980;75:131–168.62. Scott D, Fox M, Fox BW. The relationship between chromosomal aberrations, survival and DNA repair in tumor celllines of differential sensitivity to X-rays and sulphur mustard. Mutat Res. 1974;22:207–221.63. Wulf HC, Aasted A, Darre E, Neibuhr E. Sister chromatid exchanges in fishermen exposed to leaking mustard gasshells. Lancet. 1985;1:690–691.64. Sasser LB, Miller RA, Kalkwarf DR, Buschbom RL, Cushing JA. Toxicology Studies on Lewisite and Sulfur Mustard Agents:Two-Generation Reproduction Study of Sulfur Mustard (HD) in Rats. Richland, Wash: Pacific Northwest Laboratory; 1989.65. Taylor P. Anticholinesterase agents. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Basis of Therapeutics.New York, NY: Pergamon Press; 2001: 175–193.66. Albuquerque EX, Akaike A, Shaw KP, Rickett DL. The interaction of anticholinesterase agents with the acetylcholinereceptor–ionic channel complex. Fundam Appl Toxicol. 1984;4:S27–S33.67. O’Neill JJ. Non-cholinesterase effects of anticholinesterases. Fundam Appl Toxicol. 1981;1:154–169.68. Bowers MB, Goodman E, Sim VM. Some behavioral changes in man following anticholinesterase administration. JNerv Ment Dis. 1964;138:383–389.69. Craig FN, Cummings EG, Sim VM. Environmental temperature and the percutaneous absorption of a cholinesteraseinhibitor, VX. J Invest Dermatol. 1977;68:357–361.70. Johns RJ. The Effects of Low Concentrations of GB on the Human Eye. Edgewood Arsenal, Md: Medical Research Laboratory;1952. MRL Report 100.71. Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. ClinToxicol. 1974;7:1–17.72. Ward JR. Exposure to a nerve gas. In: Whittenberger JL, ed. Artificial Respiration: Theory and Applications. New York,NY: Harper & Row; 1962: 258–265.73. Program Executive Officer–Program Manager of Chemical Demilitarization. Chemical Stockpile Disposal Program FinalProgrammatic Environmental Impact Statement. Aberdeen Proving Ground, Md: Program Executive Officer–ProgramManager of Chemical Demilitarization; 1988: B-23–B-25.74. Sidell FR, Groff WA. The reactivatibility of cholinesterase inhibited by VX and sarin in man. Toxicol Appl Pharmacol.1974;27:241–252.75. Boskovic B, Kusic R. Long-term effects of acute exposure to nerve gases upon human health. In: Chemical Weapons:Destruction and Conversion. New York, NY: Crane, Russak; 1980: 113–116.76. Fullerton CS, Ursano RJ. Behavioral and psychological responses to chemical and biological warfare. Mil Med.1990;155:54–59.331
Medical Aspects of Chemical Warfare77. Chew LS, Chee KT, Yeeo JM, Jayaratnam FJ. Continuous atropine infusion in the management of organophosphorusinsecticide poisoning. Singapore Med J. 1971;12:80–85.78. LeBlanc FN, Benson BE, Gilg AD. A severe organophosphate poisoning requiring the use of an atropine drip. ClinToxicol. 1986;24:69–76.79. Metcalf RL. Historical perspective of organophosphorus ester-induced delayed neurotoxicity. In: Cranmer JM, HixsonEJ, eds. Delayed Neurotoxicity. Little Rock, Ark: Intox Press; 1984: 7–23.80. Takade DY. Delayed neurotoxicity in perspective: summary and objectives of the workshop. In: Cranmer JM, HixsonEJ, eds. Delayed Neurotoxicity. Little Rock, Ark: Intox Press; 1984: 2–6.81. Johnson MK. Organophosphorus esters causing delayed neurotoxic effects. Arch Toxicol. 1975;34:259–288.82. Davies DR, Holland P. Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickensfollowing poisoning by DFP and sarin. Biochem Pharmacol. 1972;21:3145–3151.83. Davies DR, Holland P, Rumens MJ. The relationship between the chemical structure and neurotoxicity of alkyl organophosphoruscompounds. Brit J Pharmacol. 1960;15:271–278.84. Davies, et al Cited in: Gordon JJ, Inns RH, Johnson MK, et al. The delayed neuropathic effects of nerve agents andsome other organophosphorus compounds. Arch Toxicol. 1983;52(3):71–81.85. Gordon JJ, Inns RH, Johnson MK, et al. The delayed neuropathic effects of nerve agents and some other organophosphoruscompounds. Arch Toxicol. 1983;52(3):71–81.86. Willems JL, Nicaise M, De Bisschop HC. Delayed neuropathy by the organophosphorus nerve agents soman andtabun. Arch Toxicol. 1984;55:76–77.87. Vranken MA, DeBisschop HC, Willems JL. “In vitro” inhibition of neurotoxic esterase by organophosphorus nerveagents. Arch Int Pharmacodyn. 1982;260:316–318.88. Willems JL, Palate BM, Vranken MA, DeBisschop HC. Delayed neuropathy by organophosphorus nerve agents. In:Proceedings of the International Symposium on Protection Against Chemical Warfare Agents, Stockholm, Sweden, 6–9 June1983. Umea, Sweden: National Defence Research Institute; 1983.89. Himuro K, Murayama S, Nishiyama K, et al. Distal sensory axonopathy after sarin intoxication. Neurology.1998;51(4):1195–1197.90. Hayes WJ Jr. Organic phosphorus pesticides. In: Pesticides Studied in Man. Baltimore, Md: Williams & Wilkins; 1982: 294.91. DeReuck J, Willems J. Acute parathion poisoning: myopathic changes in the diaphragm. J Neurol. 1975;208:309–314.92. Meshul CK, Boyne AF, Deshpande SS, Albuquerque EX. Comparison of the ultrastructural myopathy induced byanticholinesterase agents at the end plates of rat soleus and extensor muscles. Exp Neurol. 1985;89:96–114.93. Kawabuchi M, Boyne AF, Deshpande SS, Albuquerque EX. The reversible carbamate (–) physostigmine reducedthe size of synaptic end plate lesions induced by sarin, an irreversible organophosphate. Toxicol Appl Pharmacol.1989;97:98–106.94. Ariens AT, Meeter E, Wolthuis OL, van Benthem RMJ. Reversible necrosis at the end-plate region in striated musclesof the rat poisoned with cholinesterase inhibitors. Experientia. 1969;25:57–59.95. Dettbarn W. Pesticide induced muscle necrosis: mechanisms and prevention. Fundam Appl Toxicol. 1984;4:S18–S26.96. Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning.J Neurol Neurosurg Psychiatry. 1974;37:841–847.332
Page 3 and 4:
The Coat of Arms1818Medical Departm
Page 5:
Textbooks of Military MedicinePubli
Page 8 and 9:
MEDICAL ASPECTS o fCHEMICAL WARFARE
Page 10 and 11:
ContentsContributorsForeword by The
Page 12 and 13:
ContributorsMICHAEL ADLER, PhDResea
Page 14 and 15:
DONALD M. MAXWELL, MSResearch Chemi
Page 16 and 17:
ForewordThe US military has been co
Page 18 and 19:
PrefaceA significant concern for th
Page 20:
PrologueThe original edition of Med
Page 23 and 24:
xxii
Page 25 and 26:
Medical Aspects of Chemical Warfare
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 178 and 179:
Nerve AgentsChapter 5NERVE AGENTSFR
Page 180 and 181:
Nerve AgentsAbout 10,000 to 30,000
Page 182 and 183:
Nerve Agentsphorofluoridate (DFP) w
Page 184 and 185:
Nerve AgentsFig. 5-2. This schemati
Page 186 and 187:
Nerve AgentsExhibit 5-1 continuedis
Page 188 and 189:
Nerve Agentsactivity but only 15% t
Page 190 and 191:
Nerve AgentsTABLE 5-3CHEMICAL, PHYS
Page 192 and 193:
Nerve AgentsTABLE 5-4EFFECTS OF EXP
Page 194 and 195:
Nerve Agentsaffecting the other eye
Page 196 and 197:
Nerve Agentsmay cause severe rhinor
Page 198 and 199:
Nerve Agentsof jerks and tremor.Cen
Page 200 and 201:
Nerve Agentsand they were decreased
Page 202 and 203:
Nerve Agentsnerve agent toxicity on
Page 204 and 205:
Nerve Agentspatient. Decontaminatio
Page 206 and 207:
Nerve AgentsFig. 5-5. The Mark I ki
Page 208 and 209:
Nerve Agentsadministered intramuscu
Page 210 and 211:
Nerve Agentsthat hydroxamine reacti
Page 212 and 213:
Nerve AgentsOral administration may
Page 214 and 215:
Nerve AgentsTABLE 5-7RECOMMENDED TH
Page 216 and 217:
Nerve Agentsimpairment such as whee
Page 218 and 219:
Nerve Agentssuboptimal, manner. The
Page 220 and 221:
Nerve Agentsthan those who did not.
Page 222 and 223:
Nerve Agentssible for binding nerve
Page 224 and 225:
Nerve Agentsfor comparison was not
Page 226 and 227:
Nerve AgentsTABLE 5-11EFFECTS OF PY
Page 228 and 229:
Nerve Agentstivity of smooth muscle
Page 230 and 231:
Nerve Agents38. Grob D, Lilienthal
Page 232 and 233:
Nerve Agents77. McDonough JH, Shih
Page 234 and 235:
Nerve Agents117. McLeod CG Jr, Sing
Page 236 and 237:
Nerve Agents154. Tryphonas l, Veino
Page 238 and 239:
Nerve Agents193. Funckes AJ. Treatm
Page 240 and 241:
Nerve Agents235. Suzuki T, Morita H
Page 242:
Nerve Agents274. Pellegrini JE, Bak
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304: Medical Aspects of Chemical Warfare
Page 353: Medical Aspects of Chemical Warfare
Page 375 and 376: PROCESSMedical Aspects of Chemical
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Page 459 and 460:
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 534 and 535:
Triage of Chemical CasualtiesChapte
Page 536 and 537:
Triage of Chemical Casualtiesreceiv
Page 538 and 539:
Triage of Chemical Casualtiesentran
Page 540 and 541:
Triage of Chemical Casualtiescatego
Page 542 and 543:
Triage of Chemical CasualtiesIn a f
Page 544 and 545:
Triage of Chemical Casualtiesnose)
Page 546 and 547:
Triage of Chemical CasualtiesWith n
Page 548 and 549:
Triage of Chemical Casualties14. Sa
Page 550 and 551:
Decontamination of Chemical Casualt
Page 552 and 553:
Page 554 and 555:
Page 556 and 557:
Page 558 and 559:
Page 560 and 561:
Page 562 and 563:
Page 564 and 565:
Page 566 and 567:
Page 568 and 569:
Page 570 and 571:
Page 572 and 573:
Page 574 and 575:
Page 576 and 577:
Page 578 and 579:
Page 580:
Page 583 and 584:
Page 585 and 586:
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Page 593 and 594:
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
Page 601 and 602:
Page 603 and 604:
Page 605 and 606:
Page 607 and 608:
Page 609 and 610:
Page 611 and 612:
Page 613 and 614:
Page 615 and 616:
Page 617 and 618:
Page 619 and 620:
Page 621 and 622:
Page 623 and 624:
Page 625 and 626:
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
Page 633 and 634:
Page 635 and 636:
Page 637 and 638:
Page 639 and 640:
Page 641 and 642:
Page 643 and 644:
Page 645 and 646:
Page 647 and 648:
Page 649 and 650:
Page 651 and 652:
Page 653 and 654:
Page 655 and 656:
Page 657 and 658:
Page 659 and 660:
Page 661 and 662:
Page 663 and 664:
Page 665 and 666:
Page 667 and 668:
Page 669 and 670:
Page 671 and 672:
Page 673 and 674:
Page 675 and 676:
Page 677 and 678:
Page 679 and 680:
Page 681 and 682:
Page 683 and 684:
Page 685 and 686:
Page 687 and 688:
Page 689 and 690:
Page 691 and 692:
Page 693 and 694:
Page 695 and 696:
Page 697 and 698:
Page 699 and 700:
Page 701 and 702:
Page 703 and 704:
Page 705 and 706:
Page 707 and 708:
Page 709 and 710:
Page 711 and 712:
Page 713 and 714:
Page 715 and 716:
Page 717 and 718:
Page 719 and 720:
Page 721 and 722:
Page 723 and 724:
Page 725 and 726:
Page 727 and 728:
Page 729 and 730:
Page 731 and 732:
Page 733 and 734:
Page 735 and 736:
Page 737 and 738:
Page 739 and 740:
Page 741 and 742:
Page 743 and 744:
Page 745 and 746:
Page 747 and 748:
• Analyze using GC-MS with methan
Page 749 and 750:
Page 751 and 752:
Page 753 and 754:
Page 755 and 756:
Page 757 and 758:
Page 759 and 760:
Page 761 and 762:
Page 763 and 764:
Page 765 and 766:
Page 767 and 768:
Page 769 and 770:
Page 771 and 772:
Page 773 and 774:
Page 775 and 776:
Page 777 and 778:
Page 779 and 780:
Page 781 and 782:
Page 783 and 784:
Page 785 and 786:
Page 787 and 788:
Page 789 and 790:
Page 791 and 792:
Page 793 and 794:
Page 795 and 796:
Page 798 and 799:
Abbreviations and AcronymsAbBreviat
Page 800:
Abbreviations and AcronymsPADPRP: p
Page 803 and 804:
Page 805 and 806:
Page 807 and 808:
Page 809 and 810:
Page 811 and 812:
Page 813 and 814:
Page 815 and 816:
Page 817 and 818:
Page 819 and 820:
Page 821 and 822:
Page 823 and 824:
Page 825 and 826:
Page 827 and 828:
Page 829 and 830:
Page 831 and 832:
Page 833 and 834:
Page 835 and 836:
Page 837 and 838:
Page 839 and 840:
Page 841 and 842:
Page 843 and 844:
Page 845:
show all

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Create successful ePaper yourself

Delete template?

Save as template?